COVID-19SARS-CoV-2

Wenyan Zhang1, Wei Liu1, Jiawang Lin2

  • 1Hefei Center for Disease Control and Prevention, Hefei, Anhui Province 230061, China.

PubMed
概括

在COVID-19患者中,尤其是疾病早期,SARS-CoV-2核体 (NP) 抗原病很普遍. 较高的NP抗原水平与疾病严重程度的增加相关,可能会延迟IgM抗体的检测.